The impact of perioperative glucose variability on outcomes after hip fracture. Issue 4 (28th January 2022)

• Record Type: Journal Article
• Authors: Long, Anhua; Xie, Zongyan; Wang, Xuefei; Zhang, Yakui; Han, Dacheng
• Editors: Saisho., Yoshifumi
• Is Part Of: Medicine. Volume 101:Issue 4(2022)
• Page Start: e28728
• Publication Date: 2022-01-28
• Subjects: diabetes mellitus -- glucose variability -- hip fracture -- perioperative management; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000028728
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract : Abstract: Diabetes is considered an independent risk factor for hip fracture. In the present study, we evaluated whether perioperative glucose variability (GV) was a significant predictor of the outcomes of patients with diabetes after hip fracture. We analyzed the characteristics and outcomes of all patients with hip fractures admitted to our hospital between September 2008 and December 2012. Patients with diabetes were grouped into tertiles for GV, and multivariate survival analysis included age, sex, fracture type, mean fasting plasma glucose, and GV. Among the 1099 patients included in this study, 239 (21.7%) had diabetes. Patients with diabetes were more likely to develop infectious complications (5.4% vs 2.8%, P = .045), and experience mortality postoperatively (1 month: 5.5% vs 2.7%, P = .052; 12 months: 15.1% vs 8.7%, P = .006). The postoperative mortality rate was increased across the GV tertiles, and GV was an independent predictor of 1- and 12-month mortality after surgery. Patients with diabetes had poor prognoses after hip fracture. Perioperative GV is an independent predictor of mortality in patients with diabetes. Therefore, GV might be considered a valid additional parameter to consider in the management of these patients.